GE HealthCare Technologies Inc. (GEHC)
GEHC Stock Price Chart
Explore GE HealthCare Technologies Inc. interactive price chart. Choose custom timeframes to analyze GEHC price movements and trends.
GEHC Company Profile
Discover essential business fundamentals and corporate details for GE HealthCare Technologies Inc. (GEHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
15 Dec 2022
Employees
53.00k
Website
https://www.gehealthcare.comCEO
Peter J. Arduini
Description
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
GEHC Financial Timeline
Browse a chronological timeline of GE HealthCare Technologies Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is $1.04, while revenue estimate is $5.26bn.
Dividend declared on 24 Jul 2026
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend will be paid on 14 Aug 2026.
Earnings released on 29 Apr 2026
EPS came in at $0.99 falling short of the estimated $1.04 by -4.81%, while revenue for the quarter reached $5.13bn , beating expectations by +1.76%.
Dividend declared on 2 Apr 2026
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 May 2026.
Earnings released on 4 Feb 2026
EPS came in at $1.44 surpassing the estimated $1.40 by +2.86%, while revenue for the quarter reached $5.70bn , beating expectations by +1.51%.
Dividend declared on 9 Jan 2026
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 13 Feb 2026.
Earnings released on 29 Oct 2025
EPS came in at $1.07 surpassing the estimated $1.05 by +1.90%, while revenue for the quarter reached $5.14bn , beating expectations by +1.10%.
Dividend declared on 24 Oct 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 14 Nov 2025.
Earnings released on 30 Jul 2025
EPS came in at $1.06 surpassing the estimated $0.92 by +15.47%, while revenue for the quarter reached $5.01bn , beating expectations by +0.66%.
Dividend declared on 25 Jul 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Aug 2025.
Earnings released on 30 Apr 2025
EPS came in at $1.01 surpassing the estimated $0.91 by +10.50%, while revenue for the quarter reached $4.78bn , beating expectations by +2.52%.
Dividend declared on 25 Apr 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 May 2025.
Earnings released on 13 Feb 2025
EPS came in at $1.45 surpassing the estimated $1.26 by +15.08%, while revenue for the quarter reached $5.32bn , missing expectations by -0.23%.
Dividend declared on 14 Jan 2025
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 14 Feb 2025.
Earnings released on 30 Oct 2024
EPS came in at $1.14 surpassing the estimated $1.05 by +8.57%, while revenue for the quarter reached $4.86bn , missing expectations by -0.11%.
Dividend declared on 18 Oct 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Nov 2024.
Earnings released on 31 Jul 2024
EPS came in at $1.00 surpassing the estimated $0.98 by +2.04%, while revenue for the quarter reached $4.84bn , missing expectations by -0.75%.
Dividend declared on 19 Jul 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Aug 2024.
Earnings released on 30 Apr 2024
EPS came in at $0.90 falling short of the estimated $0.91 by -1.10%, while revenue for the quarter reached $4.65bn , missing expectations by -3.15%.
Dividend declared on 18 Apr 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 May 2024.
Earnings released on 6 Feb 2024
EPS came in at $1.18 surpassing the estimated $1.07 by +10.28%, while revenue for the quarter reached $5.21bn , beating expectations by +2.21%.
Dividend declared on 12 Jan 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Feb 2024.
Earnings released on 31 Oct 2023
EPS came in at $0.99 surpassing the estimated $0.90 by +10.00%, while revenue for the quarter reached $4.82bn , beating expectations by +0.37%.
Dividend declared on 19 Oct 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Nov 2023.
Earnings released on 25 Jul 2023
EPS came in at $0.92 surpassing the estimated $0.87 by +5.75%, while revenue for the quarter reached $4.82bn , beating expectations by +0.52%.
Dividend declared on 20 Jul 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Aug 2023.
Dividend declared on 22 May 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 15 Jun 2023.
Earnings released on 25 Apr 2023
EPS came in at $0.85 surpassing the estimated $0.79 by +7.59%, while revenue for the quarter reached $4.71bn , beating expectations by +1.58%.
Earnings released on 30 Jan 2023
EPS came in at $1.31 , while revenue for the quarter reached $4.94bn , beating expectations by +0.78%.
Earnings released on 8 Dec 2022
EPS came in at $1.07 , while revenue for the quarter reached $4.48bn .
Earnings released on 30 Sept 2022
EPS came in at $1.07 , while revenue for the quarter reached $4.58bn .
Earnings released on 31 Mar 2022
EPS came in at $0.86 , while revenue for the quarter reached $4.34bn .
Earnings released on 31 Dec 2021
EPS came in at $1.24 , while revenue for the quarter reached $4.59bn .
Earnings released on 30 Sept 2021
EPS came in at $1.11 , while revenue for the quarter reached $4.31bn .
GEHC Stock Performance
Access detailed GEHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
